These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 13999212)

  • 21. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
    Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
    Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
    Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
    Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspects of the treatment of mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O; Fischer T; Nordentoft A; Zachariae H
    Cutis; 1980 Feb; 25(2):155-7, 160-1. PubMed ID: 6153595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term topical nitrogen mustard treatment does not induce pulmonary fibrosis in MF patients.
    Nielsen M; Rasmussen K; Knudsen N; Thestrup-Pedersen K
    Acta Derm Venereol; 1994 Jan; 74(1):70-1. PubMed ID: 7908491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mycosis fungoides. A form of pleuropulmonary origin with cutaneous sclerodermiform manifestations. Treatment by application of nitrogen mustard].
    Gueguen MH
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(6):617-8. PubMed ID: 5161189
    [No Abstract]   [Full Text] [Related]  

  • 26. Precautions for personnel applying topical nitrogen mustard to patients with mycosis fungoides.
    Thestrup-Pedersen K; Christiansen JV; Zachariae H
    Dermatologica; 1982 Aug; 165(2):108-13. PubMed ID: 7141061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Topical nitrogen mustard in mycosis fungoides].
    VILANOVA X; DE MORAGAS JM
    Actas Dermosifiliogr; 1961 Sep; 52():253-64. PubMed ID: 13925940
    [No Abstract]   [Full Text] [Related]  

  • 28. Small malignant melanoma in patients with mycosis fungoides.
    Amichai B; Grunwald MH; Goldstein J; Finkelstein E; Halevy S
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):155-7. PubMed ID: 9784043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of nitrogen mustard in the treatment of mycosis fungoides.
    KIERLAND RR; WATKINS CH; SHULLENBERGER CC
    J Invest Dermatol; 1947 Oct; 9(4):195-201. PubMed ID: 20270933
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycosis fungoides, nitrogen mustard and skin cancer.
    Du Vivier A; Vonderheid EC; Van Scott EJ; Urbach F
    Br J Dermatol; 1978 Jul; 99(1):61-3. PubMed ID: 678466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mycosis fungoides and malignant cutaneous reticulo-histiocytomas].
    CROSTI A
    Ann Dermatol Syphiligr (Paris); 1951; 78(5):576-8. PubMed ID: 14915169
    [No Abstract]   [Full Text] [Related]  

  • 32. Lymphoblastomas in childhood; cutaneous manifestations.
    NELSON LM
    Calif Med; 1953 Mar; 78(3):208-12. PubMed ID: 13032796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modern therapy of mycosis fungoides].
    Roenigk HH
    Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitrogen mustard in the treatment of mycosis fungoides.
    PHILPOTT OS; WOODBURNE AR; WALDRIFF GA
    J Am Med Assoc; 1947 Nov; 135(10):631-3. PubMed ID: 20268631
    [No Abstract]   [Full Text] [Related]  

  • 36. LONG-TERM RESULTS OF X-RAY TREATMENT IN MALIGNANT DISEASE OF THE LYMPHO-RETICULAR SYSTEM.
    HALNAN KE
    Acta Unio Int Contra Cancrum; 1964; 20():1771-3. PubMed ID: 14244610
    [No Abstract]   [Full Text] [Related]  

  • 37. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
    Van Scott EJ; Kalmanson JD
    Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
    [No Abstract]   [Full Text] [Related]  

  • 38. Atypical cutaneous changes after topical treatment with nitrogen mustard in patients with mycosis fungoides.
    Reddy VB; Ramsay D; Garcia JA; Kamino H
    Am J Dermatopathol; 1996 Feb; 18(1):19-23. PubMed ID: 8721586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
    Lindahl LM; Fenger-Grøn M; Iversen L
    Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical mechlorethamine in the treatment of mycosis fungoides.
    Silver SE
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):786-7. PubMed ID: 1430412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.